Form D · Pharmaceuticals
Naurex Inc.
Evanston, IL · CIK 0001467762
Offering snapshot reported Dec 3, 2014 · SEC filing
- Reported sold
- $80M Indefinite offering
- Investors reported
- 61 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2014 | Initial | $79,999,999 | No comparison | 61 | SEC filing |
| May 14, 2014 | Initial | $24,950,507 | No comparison | 40 | SEC filing |
| Dec 21, 2012 | Initial | $37,997,768 | No comparison | 31 | SEC filing |
| May 19, 2011 | Initial | $10,959,862 | No comparison | 43 | SEC filing |
| Feb 4, 2011 | Amendment | $1,106,600 | $370,000vs Mar 23, 2010 | 24 | SEC filing |
| Mar 23, 2010 | Amendment | $736,600 | $536,600vs Jul 8, 2009 | 18 | SEC filing |
| Jul 8, 2009 | Initial | $200,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-229372
Amount sold in item 13 includes $7,914,739 from 8 non-US investors. Number of investors in item 14 includes 8 non-US investors.
Source: Form D, filed Dec 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mitchell S. Bloom | Executive |
| Ronald M. Burch | Executive |
| Edward K. Chandler | Director |
| Ian R. Ferrier | Director |
| Wilbur H. Gantz | Director |
| Edward Getz, Jr. | Director |
| Bert Getz, Jr. | Director |
| Jaswant Gidda | Executive |
| Terry P. Gould | Director |
| Robert J. Hombach | Director |
| Mohamed Amin Khan | Executive |
| Amin Khan | Executive |
| Ashish Khanna | Executive |
| J. David Leander | Executive |
| Jan E. Leetsma | Director |
| Joseph R. Moskal | Executive |
| Norbert G. Riedel | Director, Executive |
| James Schulz | Executive |
| Derek A. Small | Director |
| J.S. "Stark" Thompson | Director |
| David C. U'prichard | Director |
| Kenneth J. Widder | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1801 Maple Avenue, Suite 4300
Evanston, IL, 60201
Evanston, IL, 60201